Guy Mazué

1.2k total citations
37 papers, 904 citations indexed

About

Guy Mazué is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Guy Mazué has authored 37 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Molecular Biology. Recurrent topics in Guy Mazué's work include Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Cancer Treatment and Pharmacology (5 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Guy Mazué is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Cancer Treatment and Pharmacology (5 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Guy Mazué collaborates with scholars based in Italy, United States and Switzerland. Guy Mazué's co-authors include Marco Brughera, Paola Della Torre, Reto Brun, Michael Bray, Bernard Pécoul, Marcel Kaiser, Els Torreele, David Tweats, Bernadette Bourdin Trunz and Monica Longo and has published in prestigious journals such as Science, Annals of the New York Academy of Sciences and Journal of Biotechnology.

In The Last Decade

Guy Mazué

37 papers receiving 868 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guy Mazué Italy 18 264 249 196 140 124 37 904
G Mathé France 18 173 0.7× 285 1.1× 98 0.5× 40 0.3× 403 3.3× 105 1.4k
H. U. Gubler Japan 8 101 0.4× 467 1.9× 141 0.7× 27 0.2× 154 1.2× 10 1.4k
Adriana Vieira‐de‐Abreu Brazil 22 204 0.8× 463 1.9× 195 1.0× 56 0.4× 120 1.0× 35 1.6k
David M. Richards Germany 21 69 0.3× 315 1.3× 262 1.3× 61 0.4× 301 2.4× 30 1.7k
Esther Bettiol Switzerland 17 172 0.7× 738 3.0× 148 0.8× 168 1.2× 35 0.3× 25 1.4k
Lanjun Guo United States 17 56 0.2× 458 1.8× 200 1.0× 93 0.7× 97 0.8× 35 1.4k
Yuhua Zhang China 17 94 0.4× 253 1.0× 162 0.8× 79 0.6× 141 1.1× 63 873
Faezeh Ghasemi Iran 24 256 1.0× 446 1.8× 157 0.8× 43 0.3× 151 1.2× 57 1.2k
B. Goldberg United States 20 48 0.2× 435 1.7× 82 0.4× 94 0.7× 80 0.6× 25 1.3k
Thomas E. Hansen‐Hagge Germany 19 132 0.5× 544 2.2× 147 0.8× 46 0.3× 130 1.0× 33 1.3k

Countries citing papers authored by Guy Mazué

Since Specialization
Citations

This map shows the geographic impact of Guy Mazué's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Mazué with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Mazué more than expected).

Fields of papers citing papers by Guy Mazué

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Mazué. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Mazué. The network helps show where Guy Mazué may publish in the future.

Co-authorship network of co-authors of Guy Mazué

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Mazué. A scholar is included among the top collaborators of Guy Mazué based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Mazué. Guy Mazué is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Longo, Monica, Ivan Scandale, Charles D. Mackenzie, et al.. (2014). In vivo preliminary investigations of the effects of the benzimidazole anthelmintic drug flubendazole on rat embryos and fetuses. Reproductive Toxicology. 49. 33–42. 20 indexed citations
2.
Longo, Monica, et al.. (2012). Piperaquine phosphate: Reproduction studies. Reproductive Toxicology. 34(4). 584–597. 3 indexed citations
3.
Longo, Monica, Paolo Colombo, Michael O. Harhay, et al.. (2012). Effects of the benzimidazole anthelmintic drug flubendazole on rat embryos in vitro. Reproductive Toxicology. 36. 78–87. 26 indexed citations
4.
Torreele, Els, Bernadette Bourdin Trunz, David Tweats, et al.. (2010). Fexinidazole – A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness. PLoS neglected tropical diseases. 4(12). e923–e923. 216 indexed citations
5.
Longo, Monica, et al.. (2008). Embryotoxicity of artemisinin-type compounds. Reproductive Toxicology. 26(1). 66–67. 2 indexed citations
6.
Longo, Monica, Paola Della Torre, Francesco Giuseppe De Rosa, et al.. (2008). Investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) using the Frog Embryo Teratogenesis Assay-Xenopus (FETAX). Reproductive Toxicology. 25(4). 433–441. 24 indexed citations
7.
Longo, Monica, Paola Della Torre, Paolo Colombo, et al.. (2006). In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos. Reproductive Toxicology. 22(4). 797–810. 58 indexed citations
8.
Longo, Monica, Marco Brughera, Paolo Colombo, et al.. (2005). Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro. Reproductive Toxicology. 21(1). 83–93. 71 indexed citations
9.
Torre, Paola Della, et al.. (1999). Cardioprotection by dexrazoxane in rats treated with doxorubicin and paclitaxel. Cancer Chemotherapy and Pharmacology. 44(2). 138–142. 22 indexed citations
10.
Torre, Paola Della, et al.. (1999). Protection against doxorubicin-induced cardiotoxicity in weanling rats by dexrazoxane. Cancer Chemotherapy and Pharmacology. 43(2). 151–156. 18 indexed citations
11.
Longo, Monica, et al.. (1996). Reproductive toxicity of cabergoline in mice, rats, and rabbits. Reproductive Toxicology. 10(6). 471–483. 17 indexed citations
12.
Brughera, Marco, et al.. (1995). Overview of toxicological data on Riffabutin. Experimental and Toxicologic Pathology. 47(1). 1–9. 14 indexed citations
13.
Mazué, Guy, et al.. (1995). ANTHRACYCLINES - A REVIEW OF GENERAL AND SPECIAL TOXICITY STUDIES. International Journal of Oncology. 7(4). 713–26. 42 indexed citations
14.
15.
Iatropoulos, Michael J., et al.. (1994). Urinary bladder hyperplasia in the rat: Non-specific pathogenetic considerations using a beta-lactam antibiotic. Experimental and Toxicologic Pathology. 46(4-5). 265–274. 8 indexed citations
16.
Mazué, Guy, F. Bertolero, Luciano Garofano, Marco Brughera, & Paolo Carminati. (1992). Experience with the preclinical assessment of basic fibroblast growth factor (bFGF). Toxicology Letters. 64-65. 329–338. 40 indexed citations
17.
Mazué, Guy, et al.. (1991). Preclinical and Clinical Studies with Recombinant Human Basic Fibroblast Growth Factor. Annals of the New York Academy of Sciences. 638(1). 329–340. 58 indexed citations
18.
Betbeder, Didier, Paolo Caccia, Gianpaolo Nitti, et al.. (1991). Production of homogeneous basic fibroblast growth factor by specific enzymatic hydrolysis of larger microheterogeneous molecular forms. Journal of Biotechnology. 21(1-2). 83–92. 3 indexed citations
19.
Mazué, Guy, et al.. (1985). Haemodynamic effects of the renin inhibitor SR 42128 in conscious baboons.. PubMed. 3(3). S271–3. 3 indexed citations
20.
Mazué, Guy. (1984). Recovery from amiodarone-induced lipidosis in laboratory animals: A toxicological study. Fundamental and Applied Toxicology. 4(6). 992–999. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Mathé Breakdown of academic impact, for papers by H. U. Gubler Breakdown of academic impact, for papers by Adriana Vieira‐de‐Abreu Breakdown of academic impact, for papers by David M. Richards Breakdown of academic impact, for papers by Esther Bettiol Breakdown of academic impact, for papers by Lanjun Guo Breakdown of academic impact, for papers by Yuhua Zhang Breakdown of academic impact, for papers by Faezeh Ghasemi Breakdown of academic impact, for papers by B. Goldberg Breakdown of academic impact, for papers by Thomas E. Hansen‐Hagge
Rankless by CCL
2026